NEW YORK (GenomeWeb) –  Bioinformatics firm Repositive announced today that it has closed a Series A round of financing worth £2.5 million ($3.1 million).

Participants in the round included Ananda Social Venture Fund and Force Over Mass Capital, as well as existing investors Amadeus Capital Partners and Jonathan Milner. The company, which announced £500,000 in seed funding in early 2016, said it has raised £3.3 million to date.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.